{"id":"https://openalex.org/W7204210461","doi":"https://doi.org/10.30895/2312-7821-2026-572","title":"Safety of Psychopharmacotherapy in Patients With a Psychosomatic Profile: A Retrospective Study Using the Global Trigger Tool","display_name":"Safety of Psychopharmacotherapy in Patients With a Psychosomatic Profile: A Retrospective Study Using the Global Trigger Tool","publication_year":2026,"publication_date":"2026-08-25","ids":{"openalex":"https://openalex.org/W7204210461","doi":"https://doi.org/10.30895/2312-7821-2026-572"},"language":"en","primary_location":{"id":"doi:10.30895/2312-7821-2026-572","doi":"https://doi.org/10.30895/2312-7821-2026-572","is_oa":true,"landing_page_url":"https://doi.org/10.30895/2312-7821-2026-572","pdf_url":null,"source":{"id":"https://openalex.org/S4210210648","display_name":"Safety and Risk of Pharmacotherapy","issn_l":"2312-7821","issn":["2312-7821","2619-1164"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Safety and Risk of Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.30895/2312-7821-2026-572","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090559023","display_name":"Anastasia Anderzhanova","orcid":"https://orcid.org/0000-0001-7463-8603","observed_orcids":["https://orcid.org/0000-0001-7463-8603"]},"institutions":[{"id":"https://openalex.org/I4210101712","display_name":"Samara City N.I. Pirogov Clinical Hospital \u21161","ror":"https://ror.org/018332h72","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210101712"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. A. Anderzhanova","raw_affiliation_strings":["N.I. Pirogov City Clinical Hospital No. 1"],"raw_orcid":"https://orcid.org/0000-0001-7463-8603","affiliations":[{"raw_affiliation_string":"N.I. Pirogov City Clinical Hospital No. 1","institution_ids":["https://openalex.org/I4210101712"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060600212","display_name":"Yulia Meleshkina","orcid":"https://orcid.org/0000-0003-3768-6731","observed_orcids":["https://orcid.org/0000-0003-3768-6731"]},"institutions":[{"id":"https://openalex.org/I4210101712","display_name":"Samara City N.I. Pirogov Clinical Hospital \u21161","ror":"https://ror.org/018332h72","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210101712"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Yu. A. Meleshkina","raw_affiliation_strings":["N.I. Pirogov City Clinical Hospital No. 1"],"raw_orcid":"https://orcid.org/0000-0003-3768-6731","affiliations":[{"raw_affiliation_string":"N.I. Pirogov City Clinical Hospital No. 1","institution_ids":["https://openalex.org/I4210101712"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085276886","display_name":"Marina V. Zhuravleva","orcid":"https://orcid.org/0000-0002-9198-8661","observed_orcids":["https://orcid.org/0000-0002-9198-8661"]},"institutions":[{"id":"https://openalex.org/I17877952","display_name":"Sechenov University","ror":"https://ror.org/02yqqv993","country_code":"RU","type":"education","lineage":["https://openalex.org/I17877952"]},{"id":"https://openalex.org/I4405258012","display_name":"Federal State Budgetary Institution \u2018Scientific Centre for Expert Evaluation of Medicinal Products\u2019 of the Ministry of Health of the Russian Federation (SCEEMP)","ror":"https://ror.org/05xze5t06","country_code":"RU","type":"government","lineage":["https://openalex.org/I4210117042","https://openalex.org/I4405258012"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"M. V. Zhuravleva","raw_affiliation_strings":["I.M. Sechenov First Moscow State Medical University (Sechenov University)","Scientific Centre for Expert Evaluation of Medicinal Products"],"raw_orcid":"https://orcid.org/0000-0002-9198-8661","affiliations":[{"raw_affiliation_string":"I.M. Sechenov First Moscow State Medical University (Sechenov University)","institution_ids":["https://openalex.org/I17877952"]},{"raw_affiliation_string":"Scientific Centre for Expert Evaluation of Medicinal Products","institution_ids":["https://openalex.org/I4405258012"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027676027","display_name":"Sergey V. Yakovlev","orcid":"https://orcid.org/0000-0001-7606-8608","observed_orcids":["https://orcid.org/0000-0001-7606-8608"]},"institutions":[{"id":"https://openalex.org/I4210108300","display_name":"Russian Medical Academy of Continuous Professional Education","ror":"https://ror.org/01t6bjk79","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210108300","https://openalex.org/I4210117042"]},{"id":"https://openalex.org/I4210133425","display_name":"City Clinical Hospital","ror":"https://ror.org/02zyvys51","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210133425"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"S. V. Yakovlev","raw_affiliation_strings":["Russian Medical Academy of Continuous Professional Education","S.S. Yudin City Clinical Hospital"],"raw_orcid":"https://orcid.org/0000-0001-7606-8608","affiliations":[{"raw_affiliation_string":"Russian Medical Academy of Continuous Professional Education","institution_ids":["https://openalex.org/I4210108300"]},{"raw_affiliation_string":"S.S. Yudin City Clinical Hospital","institution_ids":["https://openalex.org/I4210133425"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033422353","display_name":"\u041c. \u0412. \u041b\u0443\u043a\u0438\u043d\u0430","orcid":"https://orcid.org/0000-0003-0032-2651","observed_orcids":["https://orcid.org/0000-0003-0032-2651","https://orcid.org/0000-0002-3748-8180"]},"institutions":[{"id":"https://openalex.org/I4210101712","display_name":"Samara City N.I. Pirogov Clinical Hospital \u21161","ror":"https://ror.org/018332h72","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210101712"]},{"id":"https://openalex.org/I4210164220","display_name":"Russian Scientific Center of Surgery","ror":"https://ror.org/05pnsh228","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210164220"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"M. V. Lukina","raw_affiliation_strings":["N.I. Pirogov City Clinical Hospital No. 1","Petrovsky National Research Center of Surgery"],"raw_orcid":"https://orcid.org/0000-0003-0032-2651","affiliations":[{"raw_affiliation_string":"N.I. Pirogov City Clinical Hospital No. 1","institution_ids":["https://openalex.org/I4210101712"]},{"raw_affiliation_string":"Petrovsky National Research Center of Surgery","institution_ids":["https://openalex.org/I4210164220"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017025197","display_name":"M. A. Balalaeva","orcid":"https://orcid.org/0000-0001-5968-3297","observed_orcids":["https://orcid.org/0000-0001-5968-3297"]},"institutions":[{"id":"https://openalex.org/I4210101712","display_name":"Samara City N.I. Pirogov Clinical Hospital \u21161","ror":"https://ror.org/018332h72","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210101712"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"M. A. Balalaeva","raw_affiliation_strings":["Main Military Clinical Hospital named after academician N.N. Burdenko","N.I. Pirogov City Clinical Hospital No. 1"],"raw_orcid":"https://orcid.org/0000-0001-5968-3297","affiliations":[{"raw_affiliation_string":"Main Military Clinical Hospital named after academician N.N. Burdenko","institution_ids":[]},{"raw_affiliation_string":"N.I. Pirogov City Clinical Hospital No. 1","institution_ids":["https://openalex.org/I4210101712"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.6815999746322632,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.6815999746322632,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.29739999771118164,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10508","display_name":"Patient Safety and Medication Errors","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8859999775886536},{"id":"https://openalex.org/keywords/psychiatric-pharmacotherapy","display_name":"psychopharmacological treatment","score":0.9670000076293945},{"id":"https://openalex.org/keywords/psychosomatic-disorders","display_name":"psychosomatic disorders","score":0.8479999899864197},{"id":"https://openalex.org/keywords/global-trigger-tool","display_name":"Global Trigger Tool","score":0.8939999938011169},{"id":"https://openalex.org/keywords/polypharmacy","display_name":"polypharmacy","score":0.7670000195503235},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.5989999771118164},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.8899999856948853},{"id":"https://openalex.org/keywords/anticholinergic-effects","display_name":"anticholinergic effects","score":0.925000011920929},{"id":"https://openalex.org/keywords/adverse-cardiovascular-events","display_name":"cardiovascular adverse events","score":0.5669999718666077},{"id":"https://openalex.org/keywords/hematological-adverse-events","display_name":"hematologic adverse events","score":0.722000002861023},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8349999785423279},{"id":"https://openalex.org/keywords/hypotension","display_name":"hypotension","score":0.8500000238418579},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.7020000219345093},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9800000190734863},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9850000143051147},{"id":"https://openalex.org/keywords/psychosomatic-inpatients","display_name":"psychosomatic inpatients","score":0.6119999885559082}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8665000200271606},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.804099977016449},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.6388000249862671},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5343000292778015},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.4733999967575073},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.44830000400543213},{"id":"https://openalex.org/C2777172819","wikidata":"https://www.wikidata.org/wiki/Q240642","display_name":"Valproic Acid","level":3,"score":0.44690001010894775},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.44600000977516174},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.4133000075817108},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4059000015258789},{"id":"https://openalex.org/C2993714069","wikidata":"https://www.wikidata.org/wiki/Q3706669","display_name":"Psychotropic drug","level":3,"score":0.38280001282691956},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3644999861717224},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36340001225471497},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3499999940395355},{"id":"https://openalex.org/C36434225","wikidata":"https://www.wikidata.org/wiki/Q1895998","display_name":"Polypharmacy","level":2,"score":0.3424000144004822},{"id":"https://openalex.org/C2779406339","wikidata":"https://www.wikidata.org/wiki/Q2991856","display_name":"Trihexyphenidyl","level":2,"score":0.34209999442100525},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.34130001068115234},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.32510000467300415},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.3095000088214874},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.29499998688697815},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2892000079154968},{"id":"https://openalex.org/C53875530","wikidata":"https://www.wikidata.org/wiki/Q814106","display_name":"Beers Criteria","level":3,"score":0.2874999940395355},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.2759999930858612},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.2750000059604645},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.26429998874664307},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.26429998874664307},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.2619999945163727},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.2531000077724457},{"id":"https://openalex.org/C2986587452","wikidata":"https://www.wikidata.org/wiki/Q938438","display_name":"Statistical analysis","level":2,"score":0.25270000100135803}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.30895/2312-7821-2026-572","doi":"https://doi.org/10.30895/2312-7821-2026-572","is_oa":true,"landing_page_url":"https://doi.org/10.30895/2312-7821-2026-572","pdf_url":null,"source":{"id":"https://openalex.org/S4210210648","display_name":"Safety and Risk of Pharmacotherapy","issn_l":"2312-7821","issn":["2312-7821","2619-1164"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Safety and Risk of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:2065f17bba544ab3b52753c78f546e24","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/2065f17bba544ab3b52753c78f546e24","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0411\u0435\u0437\u043e\u043f\u0430\u0441\u043d\u043e\u0441\u0442\u044c \u0438 \u0440\u0438\u0441\u043a \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u0438, Vol 0, Iss 0 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.30895/2312-7821-2026-572","doi":"https://doi.org/10.30895/2312-7821-2026-572","is_oa":true,"landing_page_url":"https://doi.org/10.30895/2312-7821-2026-572","pdf_url":null,"source":{"id":"https://openalex.org/S4210210648","display_name":"Safety and Risk of Pharmacotherapy","issn_l":"2312-7821","issn":["2312-7821","2619-1164"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Safety and Risk of Pharmacotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W2767763205","https://openalex.org/W3106546834","https://openalex.org/W4200560146","https://openalex.org/W4282044450","https://openalex.org/W4293053119","https://openalex.org/W4388209421","https://openalex.org/W4392673822","https://openalex.org/W4392954175","https://openalex.org/W4398222639","https://openalex.org/W4401074479","https://openalex.org/W4406627216","https://openalex.org/W4407531174","https://openalex.org/W4411126694","https://openalex.org/W4412022612","https://openalex.org/W4416294615","https://openalex.org/W7122752400"],"related_works":["https://openalex.org/W4409775240","https://openalex.org/W4221032465","https://openalex.org/W2758111407","https://openalex.org/W2058392883","https://openalex.org/W2186474831","https://openalex.org/W2977414843","https://openalex.org/W6931392362","https://openalex.org/W6945826469","https://openalex.org/W3183169090","https://openalex.org/W4387465909"],"abstract_inverted_index":{"INTRODUCTION.":[0],"Combined":[1,283],"psychopharmacotherapy":[2,62,284],"in":[3,40,63,108,182,305],"patients":[4,64,106,125],"with":[5,65,179,211,223,227,231,242,252],"comorbid":[6],"psychiatric":[7],"and":[8,28,44,57,69,81,163,201,229,245,258,265,296,303],"somatic":[9],"disorders":[10,154],"creates":[11],"a":[12,66,109],"high":[13],"risk":[14,239,289],"of":[15,31,37,59,76,84,105,120,144,171,185,214,240,260,281],"adverse":[16],"drug":[17],"reactions":[18,165],"(ADRs).":[19],"The":[20,148,271],"Global":[21,88],"Trigger":[22,89],"Tool":[23],"(GTT)":[24],"enables":[25],"active":[26],"screening":[27],"quantitative":[29],"assessment":[30],"ADRs":[32,60,85,145,297],"developing":[33],"under":[34],"the":[35,55,74,82,87,183,212],"influence":[36],"various":[38],"factors":[39],"routine":[41],"clinical":[42],"practice":[43],"helps":[45],"identify":[46,71,131],"directions":[47],"for":[48,124,277],"optimizing":[49],"therapeutic":[50],"strategy.":[51],"AIM.":[52],"To":[53],"evaluate":[54],"frequency":[56],"structure":[58],"during":[61],"psychosomatic":[67,110],"profile":[68],"to":[70,115,130,189,197,205],"associations":[72,219,292],"between":[73,293],"use":[75,170],"specific":[77,294],"drugs,":[78],"combined":[79],"psychopharmacotherapy,":[80,127],"development":[83],"using":[86,137],"Tool.":[90],"MATERIALS":[91],"AND":[92],"METHODS.":[93],"A":[94,118],"single-center":[95],"retrospective":[96,278],"study":[97],"was":[98,128,135,177],"conducted":[99],"that":[100,209,300],"included":[101],"491":[102],"medical":[103],"records":[104],"hospitalized":[107],"department":[111],"from":[112],"January":[113],"2024":[114],"March":[116],"2025.":[117],"list":[119],"27":[121],"triggers,":[122],"adapted":[123],"receiving":[126],"used":[129],"ADRs.":[132],"Statistical":[133],"analysis":[134],"performed":[136],"Fisher":[138],"exact":[139],"test.":[140],"RESULTS.":[141],"Twenty-five":[142],"types":[143],"were":[146,152,220,237,298],"identified.":[147],"most":[149],"frequently":[150],"recorded":[151],"cardiovascular":[153],"(":[155,160,166,247,255,262,267],"n":[156,161,167],"=211),":[157],"anticholinergic":[158],"effects":[159],"=113),":[162],"hematological":[164],"=89).":[168],"Concomitant":[169],"2":[172],"or":[173],"more":[174],"psychotropic":[175,215],"drugs":[176,216,295],"associated":[178],"an":[180,274,286],"increase":[181],"incidence":[184],"extrapyramidal":[186,224],"symptoms":[187],"(up":[188,196,204],"14.1%,":[190],"p":[191,199,207,248,256,263,268],"<0.001),":[192,200],"acute":[193],"urinary":[194],"retention":[195],"12.7%,":[198],"arterial":[202,250],"hypotension":[203,251],"9.4%,":[206],"<0.001)":[208],"correlated":[210],"number":[213],"used.":[217],"Known":[218],"confirmed:":[221],"antipsychotics":[222],"symptoms;":[225],"antidepressants":[226],"bleeding;":[228],"antiepileptics":[230],"hematotoxicity.":[232],"New":[233,291],"hypotheses":[234],"requiring":[235],"confirmation":[236,302],"generated:":[238],"thrombocytopenia":[241],"trihexyphenidyl":[243],"(p=0.006)":[244],"periciazine":[246],"=0.005);":[249],"valproic":[253],"acid":[254],"=0.044);":[257],"cardiotoxicity":[259],"pramipexole":[261],"=0.006)":[264],"levodopa":[266],"=0.012).":[269],"CONCLUSIONS.":[270],"GTT":[272],"is":[273,285],"effective":[275],"method":[276],"safety":[279],"audit":[280],"psychopharmacotherapy.":[282],"independent":[287],"modifiable":[288],"factor.":[290],"identified":[299],"require":[301],"validation":[304],"prospective":[306],"studies.":[307]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-08-26T00:00:00"}